Skip to main content
. 2012 Aug 15;84(10):1680–1696. doi: 10.1002/jmv.23354
Virus
 Avian influenza (H5N1)
 Adenovirus
 Beta 2 glycoprotein I (B2GPI)
 Coronavirus (corona virus)
 Crimean‐congo
 Cytomegalovirus (CMV)
 Dengue virus/dengue hemorrahic fever/dengue schock syndrome
 Ebola
 Epstein Barr (EBV)
 Hantavirus
 Hemorrhagic fever (hemorragic fever)
 Hepatitis A/B/C (HAV, HBV, HCV)
 Herpesvirus/herpes virus
 Herpes simplex virus (HSV)
 Human immunodeficiency virus (HIV)
 Influenza
 Junin (junin hemorrhagic fever)
 Lassa/lassa fever
 Marburg
 Mexican flu (H1N1)
 Parvovirus (B19)
 Respiratory tract infections
 Respiratory syncytial virus (RSV)
 Rhinovirus
 Severe acute respiratory syndrome (SARS)
 Varicella zoster (VZV)
 Viral hepatitis
 Yellow fever
Coagulation
 Activated protein C (APC)
 Antiphospholipid antibodies/anticardiolipin antibodies/lupus anticoagulant
 Antithrombin (AT)
 Bleeding/hemorrhage/hemorrhage/bleeding complication
 Coagulation
 Coagulation factor/clotting factor
d‐dimer
 Endothelial cell protein C receptor (EPCR)
 Factor XI
 Factor VIII
 Fibrin/fibrinogen
 Fibrinolysis
 Hemorrhagic/hemorrhagic complications
 Hemostasis/hemostasis
 Heparin cofactor II
 Heparan sulfate
 Plasmin–α2‐antiplasmin (PAP)
 Plasminogen activator inhibitor type I (PAI‐1)
 Platelets
 Protein C/protein S
 Prothrombin fragment 1 + 2 (F1 + 2)
 P‐selectin
 Soluble intercellular adhesion molecule (sICAM)
 Soluble vascular adhesion molecules (sVCAM)
 Tissue factor (TF)
 Tissue factor pathway inhibitor (TFPI)
 TF‐factor VIIa
 Thrombin–antithrombin (TAT)
 Thrombin‐activatable fibrinolysis inhibitor (TAFI)
 Thrombomodulin (TM)
 Thrombosis/thrombotic complication
 Tissue plasminogen activator (t‐PA)
 von Willebrand factor (VWF)
 Urokinase